Csenge Advisory Group

SEC CIK: 0001715593
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overview All 13F holders of AXSM Full Q2 2026 holdings

Shares (Q2 2026): 2,067
Value: $505.9K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of AXSM by Csenge Advisory Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,067	$505.9K	<0.1%	−740−26.4%	Reduced	Holders
Q1 2026	2,807	$474.4K	<0.1%	−1,189−29.8%	Reduced	Holders
Q4 2025	3,996	$729.8K	<0.1%	+3,996	New	Holders